Herbert Haack

Herbert Haack is an experienced professional in the fields of translational diagnostics and personalized medicine, currently serving as the Director of Translational Diagnostics at Cell Signaling Technology (CST) since October 2003. Previous roles at CST include Head of Clinical Assay Development and Scientific Project Leader, focusing on biomarker identification and assay development. Prior to CST, Herbert Haack worked at Vertex Pharmaceuticals as an Investigator for kinase oncology programs and completed postdoctoral studies at MIT's Center for Cancer Research. Herbert Haack holds a Ph.D. in Molecular Cell Biology from the Max Planck Institute for Biophysical Chemistry and a Diploma in Biology from Georg August Universitaet, Goettingen, along with study experience at the University of Cambridge.